SOMERVILLE, Mass., June 26, 2025 /PRNewswire/ -- Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that the ...

A look at the shareholders of Clancy Exploration Limited (ASX:CLY) can tell us which group is most powerful. Large companies usually have institutions as shareholders, and we usually see insiders ...

Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD). This development follows the US Food and Drug Administration's (FDA) clearance ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Cly-Del Manufacturing Co. in Waterbury has acquired a Naugatuck-based tool company, according to an announcement. Cly-Del recently purchased Semco Tool & Manufacturing Co. Inc., which produces custom ...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares 10+ Year Credit Bond Fund (AMEX: CLY) where we have detected ...

What is the current share price of Clancy Exploration Limited (CLY)? Clancy Exploration Limited's (CLY) current share price is $0.04. This constitutes a price movement of 21.57% when compared to the ...